The chipmaker is in talks to buy rival
The biotechnology company's potential COVID-19 treatment quickened recovery time in a study.
The chipmaker gave investors an encouraging third-quarter financial update.
The
The networking company raised its fiscal first-quarter earnings and revenue forecasts.
The health care services company expects its third-quarter revenue to beat
The
The pharmaceuticals company may reportedly hand ownership over to unsecured bondholders as part of its bankruptcy.
Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source